Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-22-014565

Options or other derivatives

  • COO,CFO and CS acquired 94,772 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mahal Jeetinder Singh · COO,CFO and CS

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-21 Grant or award : show line 1 in the form Stock Option (right to buy) +7,500 7,500 D
2022-03-21 Grant or award : show line 2 in the form Stock Option (right to buy) +87,272 87,272 D
Loading xslF345X03/ownership.xml…